Activation of ETB receptors increases superoxide levels in sympathetic ganglia in vivo

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 290, Issue 1, 2006, Pages

  Lau, Yanny E ^a   Galligan, James J ^a   Kreulen, David L ^a   Fink, Gregory D ^a,b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Hypertension; Oxidative stress; Reactive oxygen species; Sarafotoxin 6c; Sympathetic nervous activity

Indexed keywords

ENDOTHELIN B RECEPTOR; OXYGEN; SARAFOTOXIN; SUPEROXIDE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; PHENYLEPHRINE; SARAFOTOXINS S6; VIPER VENOM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FLUORESCENCE; GLIA CELL; HYPERTENSION; IN VIVO STUDY; MALE; MEAN ARTERIAL PRESSURE; NERVE; NONHUMAN; PRIORITY JOURNAL; RAT; SYMPATHETIC GANGLION; ANIMAL; BLOOD PRESSURE; DRUG EFFECT; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD PRESSURE; ENDOTHELIN-1; GANGLIA, SYMPATHETIC; MALE; PHENYLEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; SUPEROXIDES; VIPER VENOMS;

EID: 33644836309     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00505.2005     Document Type: Article

References (53)

1. Beswick RA, Dorrance AM, Leite R, and Webb RC. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 38: 1107-1111, 2001.
2. Boarder MR and Marriott DB. Endothelin-1 stimulation of noradrenaline and adrenaline release from adrenal chromaffin cells. Biochem Pharmacol 41: 521-526, 1991.
3. Bouloumie A, Bauersachs J, Linz W, Scholkens BA, Wiemer G, Fleming I, and Busse R. Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production. Hypertension 30: 934-941, 1997.
4. Browning KN, Zheng Z, Kreulen DL, and Travagli RA. Effects of nitric oxide in cultured prevertebral sympathetic ganglion neurons. J Pharmacol Exp Ther 286: 1086-1093, 1998.
5. Cai H and Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840-844, 2000.
6. A receptor blockade decreases vascular superoxide generation in DOCA-salt hypertension. Hypertension 42: 811-817, 2003.
7. Campese VM, Ye S, Zhong H, Yanamadala V, Ye Z, and Chiu J. Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity. Am J Physiol Heart Circ Physiol 287: H695-H703, 2004.
8. Ceccatelli S, Lundberg JM, Zhang X, Aman K, and Hokfelt T. Immunohistochemical demonstration of nitric oxide synthase in the peripheral autonomic nervous system. Brain Res 656: 381-395, 1994.
9. Chen X, Touyz RM, Park JB, and Schiffrin EL. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 38: 606-611, 2001.
10. B receptors by sympathetic neurons in DOCA-salt hypertensive rats. Hypertension 43: 1048 -1054, 2004.
11. Dai X and Kreulen DL. Superoxide anion is elevated in sympathetic neurons in DOCA-salt hypertension via activation of NADPH oxidase. Am J Physiol. In press.
12. Damon DH. Postganglionic sympathetic neurons express endothelin. Am J Physiol Regul Integr Comp Physiol 274: R873-R878, 1998.
13. DeLano FA, Balete R, and Schmid-Schonbein GW. Control of oxidative stress in microcirculation of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 288: H805-H812, 2005.
14. Duffy SJ, Gokce N, Holbrook M, Huang A, Frei B, Keaney JF Jr, and Vita JA. Treatment of hypertension with ascorbic acid. Lancet 354: 2048-2049, 1999.
15. B receptors in rats. Biochem Biophys Res Commun 199: 1461-1465, 1994.
16. Giaid A, Gibson SJ, Ibrahim SI, Legon S, Bloom SR, Yanagisawa M, Masaki T, Varndell IM, and Plolak M. Endothelin-1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia. Proc Natl Acad Sci USA 86: 7634-7638, 1989.
17. Gomez-Alamillo C, Juncos LA, Cases A, Haas JA, and Romero JC. Interactions between vasoconstrictors and vasodilators in regulating hemodynamics of distinct vascular beds. Hypertension 42: 831-836, 2003.
18. Grunfeld S, Hamilton CA, Mesaros S, McClain SW, Dominiczak AF, Bohr DF, and Malinski T. Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension 26: 854-857, 1995.
19. Heitzer T, Wenzel U, Hink U, Krollner D, Skatchkov M, Stahl RA, MacHarzina R, Brasen JH, Meinertz T, and Munzel T. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int 55: 252-260, 1999.
20. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, and Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 346: 1954-1962, 2002.
21. Jordan J, Ghadge GD, Prehn JH, Toth PT, Roos RP, and Miller RJ. Expression of human copper/zinc-superoxide dismutase inhibits the death of rat sympathetic neurons caused by withdrawal of nerve growth factor. Mol Pharmacol 47: 1095-1100, 1995.
22. Just A, Olson AJ, Falck JR, and Arendshorst WJ. NO and NO-independent mechanisms mediate ETB receptor buffering of ET-1-induced renal vasoconstriction in the rat. Am J Physiol Regul Integr Comp Physiol 288: R1168-R1177, 2005.
23. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, and Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111: 1201-1209, 2003.
24. Lariviere R, Thibault G, and Schriffrin EL. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension 21: 294-300, 1993.
25. B receptors (Abstract). Fed Proc 18: A646, 2004.
26. Li L, Fink GD, Watts SW, Northcott CA, Galligan JJ, Pagano PJ, and Chen AF. Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension. Circulation 107: 1053-1058, 2003.
27. Majid DS and Nishiyama A. Nitric oxide blockade enhances renal responses to superoxide dismutase inhibition in dogs. Hypertension 39: 293-297, 2002.
28. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Forstermann U, Meinertz T, Griendling K, and Munzel T. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90: E58-E65, 2002.
29. Moreland S, McMullen D, Abboa-Offei B, and Seymour A. Evidence for a differential location of vasoconstrictor endothelin receptors in the vasculature. Br J Pharmacol 112: 704-708, 1994.
30. Mortensen LH. Endothelin and the central and peripheral nervous systems: a decade of endothelin research. Clin Exp Pharmacol Physiol 26: 980-984, 1999.
31. Nakamura K, Sasaki S, Moriguchi J, Morimoto S, Miki S, Kawa T, Itoh H, Nakata T, Takeda K, and Nakagawa M. Central effects of endothelin and its antagonists on sympathetic and cardiovascular regulation in SHR-SP. J Cardiovasc Pharmacol 33: 876-882, 1999.
32. Onuma S and Nakanishi K. Superoxide dismustase mimetic tempol decreases blood pressure by increasing renal medullary blood flow in hyperinsulinemic- hypertensive rats. Metabolism 53: 1305-1308, 2004.
33. - and NO in the thick ascending limg. Hypertension 39: 591-596, 2002.
34. Pollock DM. Renal endothelin in hypertension. Curr Opin Nephrol Hypertens 9: 157-164, 2000.
35. Quinson N, Miolan JP, and Niel JP. Muscarinic receptor activation is a prerequisite for the endogenous release of nitric oxide modulating nicotinic transmission within the coeliac ganglion in the rabbit. Neuroscience 95: 1129-1138, 2000.
36. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, and Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97: 1916-1923, 1996.
37. Reinhart GA, Preusser LC, Burke SE, Wessale JL, Wegner CD, Opgenorth TJ, and Cox BF. Hypertension induced by blockade of ET(B) receptors in conscious nonhuman primates: role of ET(A) receptors. Am J Physiol Heart Circ Physiol 283: H1555-H1561, 2002.
38. Schnackenberg CG and Wilcox CS. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin F2 alpha. Hypertension 33: 424-428, 1999.
39. Sedeek MH, Llinas MT, Drummond H, Fortepiani L, Abram SR, Alexander BT, Reckelhoff JF, and Granger JP. Role of reactive oxygen species in endothelin-induced hypertension. Hypertension 42: 806-810, 2003.
40. Shokoji T, Nishiyama A, Fujisawa Y, Hitomi H, Kiyomoto H, Takahashi N, Kimura S, Kohno M, and Abe Y. Renal sympathetic nerve responses to tempol in spontaneously hypertensive rats. Hypertension 41: 266-273, 2003.
41. Shokoji T, Fujisawa Y, Kimura S, Rahman M, Kiyomoto H, Matsubara K, Moriwaki K, Aki Y, Miyatake A, Kohno M, Abe Y, and Nishiyama A. Effects of local administrations of tempol and diethyldithio-carbamic on peripheral nerve activity. Hypertension 44: 236-243, 2004.
42. Somers MJ, Mavromatis K, Galis ZS, and Harrison DG. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation 101: 1722-1728, 2000.
43. Tabuchi Y, Nakamaru M, Rakugi H, Nagano M, Mikami H, and Ogihara T. Endothelin inhibits presynaptic adrenergic neurotransmission in rat mesenteric artery. Biochem Biophys Res Commun 161: 803-808, 1989.
44. Tammariello SP, Quinn MT, and Estus S. NADPH oxidase contributes directly to oxidative stress and apoptosis in nerve growth factor-deprived sympathetic neurons. J Neurosci 20: 1-5, 2000.
45. Ungvari Z, Csiszar A, Huang A, Kaminski PM, Wolin MS, and Koller A. High pressure induces superoxide production in isolated arteries via protein kinase C-dependent activation of NAD(P)H oxidase. Circulation 108: 1253-1258, 2003.
46. Ungvari Z, Csiszar A, Kaminski PM, Wolin MS, and Koller A. Chronic high pressure-induced arterial oxidative stress: involvement of protein kinase C-dependent NAD(P)H oxidase and local renin-angiotensin system. Am J Pathol 165: 219-226, 2004.
47. Xu H, Fink GD, Chn A, Watts S, and Galligan JJ. Nitric-oxide independent effects of tempol on sympathetic nerve activity and blood pressure in normotensive rats. Am J Physiol Heart Circ Physiol 281: H975-H980, 2001.
48. Xu H, Fink GD, and Galligan JJ. Nitric-oxide-independent effects of tempol on sympathetic nerve activity and blood pressure in DOCA-salt rats. Am J Physiol Heart Circ Physiol 283: H885-H893, 2002.
49. - in DOCA-salt rats. Hypertension 43: 329-334, 2004.
50. B receptor of the canine stellate ganglionic transmission. J Pharmacol Exp Ther 290: 1175-1181, 1999.
51. Zanzinger J and Czachurski J. Chronic oxidative stress in the RVLM modulates sympathetic control of circulation in pigs. Pflügers Arch 439: 489-494, 2000.
52. Zimmerman MC, Lazartigues E, Lang JA, Sinnayah P, Ahmad IM, Spitz DR, and Davisson RL. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res 91: 1038-1045, 2002.
53. Zimmerman MC, Lazartigues E, Sharma RV, and Davisson RL. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res 95: 210-216, 2004.